CWM
COGT icon

Crowley Wealth Management’s Cogent Biosciences COGT Stock Holding History

Crowley Wealth Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,700
Closed -$24.4K – 72
2025
Q3 		$24.4K Hold
1,700
– – 0.02% 207
2025
Q2 		$12.2K Hold
1,700
– – 0.01% 251
2025
Q1 		$10.2K Buy
+1,700
New +$13.3K 0.01% 261

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Crowley Wealth Management's COGT Position: Q4 2025 in Review

Crowley Wealth Management sold out of Cogent Biosciences (COGT) in Q4 2025, closing a stake of 1,700 shares — an estimated $24.4K sold.

Crowley Wealth Management first reported a position in COGT in Q1 2025 and held it in 3 quarters. The position peaked at $24.4K in Q3 2025. 267 funds tracked by Wall St. Rank hold COGT as of Q4 2025.

  • Crowley Wealth Management reported no remaining Cogent Biosciences position as of Q4 2025 after selling out during the quarter.
  • Crowley Wealth Management sold 1,700 Cogent Biosciences shares in Q4 2025, an estimated $24.4K.
  • Crowley Wealth Management first reported a position in Cogent Biosciences in Q1 2025 and held it in 3 quarters.
  • Crowley Wealth Management's Cogent Biosciences position peaked at $24.4K in Q3 2025.
  • 267 funds tracked by Wall St. Rank held Cogent Biosciences as of Q4 2025.

Based on Crowley Wealth Management's 13F filing for Q4 2025.